BMY Gains Attention as Bayer Reports FXIa Trial Success
BMY Gains Attention as Bayer Reports FXIa Trial Success Vardah Gill Mon, December 1, 2025 at 3:27 AM GMT+8 2 min read In this article: BMY -0.10% BAYRY +0.57% JNJ -0.31% Bristol-Myers Squibb Company (...